Please enable Javascript to watch this video With the mainstream attitude toward weed continuing to shift to a very positive (and quite lucrative) place, an apparent windfall of medical studies have unleashed their findings on the general public in the name of science. We already knew that weed may help

Here is a great editorial by Judith Stamps which addresses something we are hearing often today – the “lack of clinical trials” that demonstrate the effectiveness of marijuana as medicine and proposes that the large-scale trial mentality is wrong for cannabis.  If you’ve been following current events on medical cannabis, you will have heard its

According to results of an animal study published in Journal of Leukocyte Biology in June 2015, the cannabinoid delta-9-tetrahydrocannabinol (THC) may be a safe and effective alternative or add-on therapy in the prevention of organ and tissue transplant rejection. What is Organ Transplantation? When a person’s organs or tissues begin to fail as a

Marijuana and its use has been studied over the course of the last few decades more so than even many leading FDA-approved pharmaceutical drugs, with researchers categorizing the effects of marijuana to a much greater degree than many of the pharmaceutical drugs you or your family may currently be taking.

If it were left up to voters, America would loosen some of its restrictions and penalties for marijuana. Over seven in ten voters (72%) support reducing penalties for possessing small amounts of marijuana from jail time to a fine. Six in ten voters (61%) support allowing state regulated sales of

Here is a link to a huge collection of CBD Research findings, organized by condition.   Conditions listed include: General Acne ADD/ADHD Addiction AIDS ALS Alzheimer’s Anorexia Antibiotic resistance Anxiety Atherosclerosis Arthritis Asthma Autism Bipolar Cancer Colitis/Crohn’s Depression Diabetes Endocrine disorders Epilepsy/seizure Fibromyalgia Glaucoma Heart disease Huntington’s Inflammation Irritable bowel Kidney

A study published in November 2014 in Molecular Cancer Therapeutics and conducted at St. George’s University of London’s Department of Oncology has found that the use of cannabinoids, specifically delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), may be useful in treating high-grade gliomas, potentially slowing the disease’s progression. Some of the results from this study, summarized by MedicalJane.com: